These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1557733)

  • 1. [The endothelial cell as an endocrine organ--endothelin].
    Forslund T; Metsärinne K
    Tidsskr Nor Laegeforen; 1992 Feb; 112(5):648-52. PubMed ID: 1557733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides.
    Simonson MS; Dunn MJ
    J Lab Clin Med; 1992 Jun; 119(6):622-39. PubMed ID: 1317401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin.
    Lüscher TF
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S15-22. PubMed ID: 1724999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin in cardiopulmonary disease: factor paracrine vs neurohumoral.
    Stewart DJ
    Eur Heart J; 1993 Nov; 14 Suppl I():48-54. PubMed ID: 7904941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin, endothelin receptors, and endothelin antagonists.
    Lüscher TF
    Curr Opin Nephrol Hypertens; 1994 Jan; 3(1):92-8. PubMed ID: 7850417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased endothelin release by cultured human smooth muscle cells from atherosclerotic coronary arteries.
    Haug C; Voisard R; Lenich A; Baur R; Höher M; Osterhues H; Hannekum A; Vogel U; Mattfeldt T; Hombach V; Grünert A
    Cardiovasc Res; 1996 May; 31(5):807-13. PubMed ID: 8763411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin as a clinical target in the treatment of systemic hypertension.
    Prasad VS; Palaniswamy C; Frishman WH
    Cardiol Rev; 2009; 17(4):181-91. PubMed ID: 19525680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin: role in hypertension.
    Schiffrin EL
    Biol Res; 1998; 31(3):199-208. PubMed ID: 9830507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelins and anti-endothelins.
    Bhatt AD
    J Assoc Physicians India; 1997 Nov; 45(11):868-72. PubMed ID: 11229190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endothelin in cardiovascular disease.
    Agapitov AV; Haynes WG
    J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):1-15. PubMed ID: 11984741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of endothelin in cardiovascular disease.
    Schiffrin EL; Intengan HD; Thibault G; Touyz RM
    Curr Opin Cardiol; 1997 Jul; 12(4):354-67. PubMed ID: 9263647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelin in hypertension.
    Schiffrin EL
    Vascul Pharmacol; 2005 Jun; 43(1):19-29. PubMed ID: 15955745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endothelium and control of blood vessel function in health and disease.
    Schiffrin EL
    Clin Invest Med; 1994 Dec; 17(6):602-20. PubMed ID: 7895424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.